{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:17:56Z","timestamp":1776273476721,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-NHLHCRF-YS-02"],"award-info":[{"award-number":["2022-NHLHCRF-YS-02"]}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No.7232145"],"award-info":[{"award-number":["No.7232145"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Care for Senior Officials Foundation","award":["2020YB27"],"award-info":[{"award-number":["2020YB27"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10067-024-07178-x","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:55:42Z","timestamp":1730300142000},"page":"3799-3807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of the 2018 (New) ENMC Classification Criteria for Dermatomyositis in Chinese Patients with Idiopathic Inflammatory Myopathies"],"prefix":"10.1007","volume":"43","author":[{"given":"Puli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5472-9292","authenticated-orcid":false,"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"7178_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"7178_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"7178_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/WCO.0000000000000855","volume":"33","author":"J Tanboon","year":"2020","unstructured":"Tanboon J, Uruha A, Stenzel W, Nishino I (2020) Where are we moving in the classification of idiopathic inflammatory myopathies? Curr Opin Neurol 33:590\u2013603","journal-title":"Curr Opin Neurol"},{"key":"7178_CR4","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727)","volume":"95","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y, Uzunhan Y, Toquet S, Leroux G, Gallay L, Marquet A et al (2020) Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases. Neurology 95:e70-78. https:\/\/doi.org\/10.1212\/WNL.0000000000009727)","journal-title":"Neurology"},{"key":"7178_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP et al (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101:48\u201355","journal-title":"J Autoimmun"},{"key":"7178_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/rheumatology\/kex516","volume":"57","author":"J Aouizerate","year":"2018","unstructured":"Aouizerate J, De Antonio M, Bader Meunier B, Barnerias C, Bodemer C, Isapof A et al (2018) Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis. Rheumatology (Oxford) 57:873\u2013879","journal-title":"Rheumatology (Oxford)"},{"key":"7178_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","volume":"19","author":"H Yang","year":"2017","unstructured":"Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y et al (2017) Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19:259","journal-title":"Arthritis Res Ther"},{"key":"7178_CR8","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups [published correction appears in Ann Rheum Dis. Ann Rheum Dis 76:1955\u20131964","journal-title":"Ann Rheum Dis"},{"key":"7178_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280:8\u201323","journal-title":"J Intern Med"},{"key":"7178_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen AL, Allenbach Y, Stenzel W, Benveniste O (2020) 239th ENMC international workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 December 2018. Neuromuscul Disord 30:70\u201392","journal-title":"Neuromuscul Disord"},{"key":"7178_CR11","first-page":"767","volume":"31","author":"H Linklater","year":"2013","unstructured":"Linklater H, Pipitone N, Rose MR, Norwood F, Campbell R, Salvarani C et al (2013) Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol 31:767\u2013769","journal-title":"Clin Exp Rheumatol"},{"key":"7178_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.semarthrit.2019.12.001","volume":"50","author":"S Barsotti","year":"2020","unstructured":"Barsotti S, Dastmalchi M, Notarnicola A, Leclaire V, Dani L, Gheorghe K et al (2020) Performance of the new EULAR\/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort. Semin Arthritis Rheum 50:492\u2013497","journal-title":"Semin Arthritis Rheum"},{"key":"7178_CR13","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/1756-185X.13605","volume":"22","author":"X Zhang","year":"2019","unstructured":"Zhang X, Yang X, Ji L, Zhang Z (2019) Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR\/ACR in Chinese patients. Int J Rheum Dis 22:1278\u20131282","journal-title":"Int J Rheum Dis"},{"key":"7178_CR14","doi-asserted-by":"crossref","unstructured":"Jinnin M, Ohta A, Ishihara S, Amano H, Atsumi T, Fujimoto M, et al (2020) First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)\/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort [published correction appears in Ann Rheum Dis. 2021 Sep;80(9): e153]. Ann Rheum Dis 79(3):387\u2013392","DOI":"10.1136\/annrheumdis-2019-215488"},{"issue":"3","key":"7178_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/rheumatology\/key343","volume":"58","author":"MJS Parker","year":"2019","unstructured":"Parker MJS, Oldroyd A, Roberts ME, Lilleker JB, Betteridge ZE, McHugh NJ et al (2019) The performance of the European League Against Rheumatism\/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort. Rheumatology (Oxford) 58(3):468\u2013475","journal-title":"Rheumatology (Oxford)"},{"key":"7178_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4103\/0028-3886.232296","volume":"66","author":"S Challa","year":"2018","unstructured":"Challa S, Jakati S, Uppin MS, Kannan MA, Liza R, Jagarlapudi MM (2018) Idiopathic inflammatory myopathies in adults: a comparative study of Bohan and Peter and European Neuromuscular Center 2004 criteria. Neurol India 66:767\u2013771","journal-title":"Neurol India"},{"key":"7178_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3349\/ymj.2021.62.5.424","volume":"62","author":"SW Chung","year":"2021","unstructured":"Chung SW, Yoo IS, Kim J, Kang SW, Kwon M, Joung CI et al (2021) Comparison of the 2017 EULAR\/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients. Yonsei Med J 62:424\u2013430","journal-title":"Yonsei Med J"},{"key":"7178_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/WCO.0000000000000740","volume":"32","author":"J Tanboon","year":"2019","unstructured":"Tanboon J, Nishino I (2019) Classification of idiopathic inflammatory myopathies: pathology perspectives. Curr Opin Neurol 32:704\u2013714","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"7178_CR19","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1136\/annrheumdis-2017-212701)","volume":"77","author":"AN Malaviya","year":"2018","unstructured":"Malaviya AN (2018) 2017 EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why? Ann Rheum Dis 77(11):e77. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212701)","journal-title":"Ann Rheum Dis"},{"key":"7178_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/13497413.2018.1481571","volume":"41","author":"S Barsotti","year":"2018","unstructured":"Barsotti S, Lundberg IE (2018) Myositis an evolving spectrum of disease. Immunol Med 41:46\u201354","journal-title":"Immunol Med"},{"issue":"11","key":"7178_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","volume":"19","author":"T Khoo","year":"2023","unstructured":"Khoo T, Lilleker JB, Thong BY, Leclair V, Lamb JA, Chinoy H (2023) Epidemiology of the idi-pathic inflammatory myopathies. Nat Rev Rheumatol 19(11):695\u2013712","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"7178_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s13023-022-02570-9","volume":"17","author":"T Namsrai","year":"2022","unstructured":"Namsrai T, Parkinson A, Chalmers A, Lowe C, Cook M, Phillips C et al (2022) Diagnostic delay of myositis: an integrated systematic review. Orphanet J Rare Dis 17(1):420","journal-title":"Orphanet J Rare Dis"},{"key":"7178_CR23","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F et al (2018) Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 75:1528\u20131537","journal-title":"JAMA Neurol"},{"key":"7178_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/jnen\/nly017","volume":"77","author":"Y Hou","year":"2018","unstructured":"Hou Y, Luo YB, Dai T, Shao K, Li W, Zhao Y et al (2018) Revisiting Pathological classification criteria for adult idiopathic inflammatory myopathies: indepth analysis of muscle biopsies and correlation between pathological diagnosis and clinical manifestations. J Neuropathol Exp Neurol 77:395\u2013404","journal-title":"J Neuropathol Exp Neurol"},{"key":"7178_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11926-018-0733-5","volume":"20","author":"PW Wolstencroft","year":"2018","unstructured":"Wolstencroft PW, Fiorentino DF (2018) Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies. Curr Rheumatol Rep 20:28","journal-title":"Curr Rheumatol Rep"},{"key":"7178_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14:269\u2013278","journal-title":"Nat Rev Rheumatol"},{"key":"7178_CR27","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","volume":"98","author":"J Tanboon","year":"2022","unstructured":"Tanboon J, Inoue M, Saito Y, Tachimori H, Hayashi S, Noguchi S et al (2022) Dermatomyositis: muscle pathology according to antibody subtypes. Neurology 98:e739-749","journal-title":"Neurology"},{"key":"7178_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","volume":"88","author":"A Uruha","year":"2017","unstructured":"Uruha A, Nishikawa A, Tsuburaya RS, Hamanaka K, Kuwana M, Watanabe Y et al (2017) Sarcoplasmic MxA expression: a valuable marker of dermatomyositis. Neurology 88:493\u2013500","journal-title":"Neurology"},{"key":"7178_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/nan.12519","volume":"45","author":"A Uruha","year":"2019","unstructured":"Uruha A, Allenbach Y, Charuel JL, Musset L, Aussy A, Boyer O et al (2019) Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis. Neuropathol Appl Neurobiol 45:513\u2013522","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"7178_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaad.2017.12.055","volume":"79","author":"B Patel","year":"2018","unstructured":"Patel B, Khan N, Werth VP (2018) Applicability of EULAR\/ACR classification criteria for dermatomyositis to amyopathic disease. J Am Acad Dermatol 79(1):77-83.e1","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"7178_CR31","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/bjd.15607","volume":"179","author":"C Thompson","year":"2018","unstructured":"Thompson C, Piguet V, Choy E (2018) The pathogenesis of dermatomyositis. Br J Dermatol 179(6):1256\u20131262","journal-title":"Br J Dermatol"},{"issue":"9","key":"7178_CR32","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/art.42150","volume":"74","author":"H So","year":"2022","unstructured":"So H, So J, Lam TT, Wong VT, Ho R, Li WL, Mok CC et al (2022) Performance of the 2017 European Alliance of Associations for Rheumatology\/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity. Arthritis Rheumatol 74(9):1588\u20131592","journal-title":"Arthritis Rheumatol"},{"key":"7178_CR33","doi-asserted-by":"publisher","unstructured":"Wang X, De Moll E, Koschitzky M, Shihab N, Khattri S, Phelps R (2024) Clinically amyopathic dermatomyositis: clinical, laboratory, and histopathological features. J Cutan Pathol, Published online July 15, 2024.\u00a0https:\/\/doi.org\/10.1111\/cup.14691)","DOI":"10.1111\/cup.14691"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07178-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T11:04:58Z","timestamp":1732187098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07178-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["7178"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07178-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of the China-Japan Friendship Hospital (2020\u201311-K08). All patients provided written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics and consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}